Symphogen is primarily funded by international healthcare focused investors
Shareholders have ultimate authority over Symphogen and exercise their right to make decisions at general meetings in person, by proxy or by correspondence.
At the Annual General Meeting, shareholders approve the annual report and elect Board members and the independent auditor.
Our share capital is divided into eleven different share classes (further specified in note 4.2 of the consolidated financial statements) with different rights regarding proceeds, distributions, and qualifications for major decisions regarding our strategy. Our shareholders have entered into a Shareholders’ Agreement, which among other things governs the casting of votes, special majority qualifications for certain shareholder decisions, and rights associated with selling and buying shares.